Gene Symbol | Gene ID | Gene Info |
---|---|---|
Meis2
|
ENSMUSG00000027210.14 | Meis homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_115852535_115853157 | Meis2 | 16021 | 0.283428 | 0.69 | 7.5e-09 | Click! |
chr2_116059776_116059953 | Meis2 | 1022 | 0.503204 | 0.68 | 1.5e-08 | Click! |
chr2_116056295_116056468 | Meis2 | 2461 | 0.259368 | 0.67 | 2.5e-08 | Click! |
chr2_116055958_116056155 | Meis2 | 2786 | 0.241479 | 0.66 | 3.4e-08 | Click! |
chr2_116042788_116043285 | Meis2 | 990 | 0.552631 | 0.65 | 7.4e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_6727792_6729098 | 16.96 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr11_4572974_4574056 | 10.94 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chr10_120366214_120366504 | 7.84 |
1700006J14Rik |
RIKEN cDNA 1700006J14 gene |
2146 |
0.28 |
chr1_155693534_155693775 | 7.61 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
6663 |
0.21 |
chr8_20372500_20373383 | 7.13 |
Gm7807 |
predicted gene 7807 |
8140 |
0.18 |
chr4_110287770_110287961 | 7.10 |
Elavl4 |
ELAV like RNA binding protein 4 |
338 |
0.93 |
chr10_36555386_36555609 | 6.68 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
48090 |
0.17 |
chr8_20604856_20605288 | 6.56 |
Gm21112 |
predicted gene, 21112 |
8031 |
0.17 |
chr10_3417310_3417750 | 6.41 |
Gm24482 |
predicted gene, 24482 |
7493 |
0.25 |
chr7_70067925_70068444 | 6.08 |
Gm24120 |
predicted gene, 24120 |
110280 |
0.06 |
chr4_41612407_41612596 | 6.08 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
19143 |
0.1 |
chr3_121724172_121724437 | 5.98 |
F3 |
coagulation factor III |
734 |
0.39 |
chr2_116201357_116201527 | 5.86 |
2810405F15Rik |
RIKEN cDNA 2810405F15 gene |
125346 |
0.05 |
chr3_58136058_58136278 | 5.67 |
4921539H07Rik |
RIKEN cDNA 4921539H07 gene |
19115 |
0.16 |
chr2_63273724_63274213 | 5.64 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
89681 |
0.09 |
chr4_3082761_3083956 | 5.54 |
Vmn1r-ps2 |
vomeronasal 1 receptor, pseudogene 2 |
21234 |
0.18 |
chr6_97693391_97693612 | 5.52 |
Gm24565 |
predicted gene, 24565 |
36938 |
0.16 |
chr17_35701467_35701700 | 5.51 |
Ddr1 |
discoidin domain receptor family, member 1 |
381 |
0.67 |
chr1_89550370_89550583 | 5.26 |
Gm25180 |
predicted gene, 25180 |
12884 |
0.18 |
chr1_180791165_180791465 | 5.11 |
H3f3a |
H3.3 histone A |
22219 |
0.09 |
chr3_34503986_34504142 | 5.11 |
Gm29135 |
predicted gene 29135 |
21857 |
0.16 |
chr10_75994691_75995012 | 5.05 |
Gm16220 |
predicted gene 16220 |
859 |
0.4 |
chr3_19566788_19567409 | 4.94 |
Gm23330 |
predicted gene, 23330 |
6845 |
0.18 |
chr10_51235693_51235863 | 4.93 |
Gm5040 |
predicted gene 5040 |
3051 |
0.33 |
chr4_48335165_48335701 | 4.90 |
Gm12435 |
predicted gene 12435 |
9797 |
0.22 |
chr6_96286333_96286534 | 4.87 |
1700123L14Rik |
RIKEN cDNA 1700123L14 gene |
120190 |
0.06 |
chr1_169747607_169747817 | 4.84 |
Rgs4 |
regulator of G-protein signaling 4 |
70 |
0.98 |
chr9_35360460_35360651 | 4.82 |
2610105M22Rik |
RIKEN cDNA 2610105M22 gene |
2558 |
0.24 |
chr18_22713787_22714204 | 4.78 |
Nol4 |
nucleolar protein 4 |
114367 |
0.07 |
chr11_32000283_32000717 | 4.77 |
Nsg2 |
neuron specific gene family member 2 |
2 |
0.98 |
chr3_18905759_18906119 | 4.74 |
Gm30341 |
predicted gene, 30341 |
152862 |
0.04 |
chr6_94865589_94865740 | 4.71 |
Gm44100 |
predicted gene, 44100 |
16831 |
0.16 |
chr4_23982818_23983489 | 4.67 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr10_86961941_86962146 | 4.66 |
Gm16271 |
predicted gene 16271 |
10173 |
0.15 |
chr7_99351180_99351446 | 4.59 |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
1684 |
0.3 |
chr8_106378494_106378910 | 4.57 |
Zfp90 |
zinc finger protein 90 |
36625 |
0.13 |
chr17_3275020_3275269 | 4.57 |
Gm34035 |
predicted gene, 34035 |
8063 |
0.17 |
chr16_3236385_3237472 | 4.54 |
Gm23215 |
predicted gene, 23215 |
12656 |
0.18 |
chr6_31948060_31948249 | 4.53 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
102092 |
0.07 |
chr9_33822829_33823010 | 4.52 |
Gm47784 |
predicted gene, 47784 |
38284 |
0.16 |
chr5_89846665_89846837 | 4.52 |
Gm25758 |
predicted gene, 25758 |
17880 |
0.24 |
chr8_26526511_26526817 | 4.51 |
Gm31983 |
predicted gene, 31983 |
42012 |
0.12 |
chr19_28453023_28453301 | 4.50 |
Glis3 |
GLIS family zinc finger 3 |
87258 |
0.09 |
chr8_83206069_83206220 | 4.47 |
Gm10645 |
predicted gene 10645 |
39974 |
0.12 |
chr18_83523941_83524284 | 4.37 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr8_9124477_9125000 | 4.36 |
4933430N04Rik |
RIKEN cDNA 4933430N04 gene |
7550 |
0.18 |
chr17_78415277_78415578 | 4.36 |
Fez2 |
fasciculation and elongation protein zeta 2 (zygin II) |
2264 |
0.26 |
chr3_89696244_89696704 | 4.35 |
Adar |
adenosine deaminase, RNA-specific |
18548 |
0.14 |
chr8_45658146_45658303 | 4.33 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
68 |
0.98 |
chr13_97253425_97254036 | 4.32 |
Enc1 |
ectodermal-neural cortex 1 |
12625 |
0.16 |
chr18_55733414_55733925 | 4.28 |
Gm26959 |
predicted gene, 26959 |
12559 |
0.26 |
chr16_33605736_33606716 | 4.27 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr8_48376860_48377086 | 4.25 |
Tenm3 |
teneurin transmembrane protein 3 |
76874 |
0.11 |
chr8_62284797_62285008 | 4.24 |
Gm2961 |
predicted gene 2961 |
90690 |
0.09 |
chr13_71165659_71165842 | 4.19 |
Mir466f-4 |
microRNA 466f-4 |
58661 |
0.15 |
chr4_62613321_62613879 | 4.18 |
Rgs3 |
regulator of G-protein signaling 3 |
5920 |
0.18 |
chr9_108587464_108588439 | 4.17 |
Gm49209 |
predicted gene, 49209 |
899 |
0.26 |
chr3_136007931_136008143 | 4.15 |
Gm5281 |
predicted gene 5281 |
43651 |
0.12 |
chr7_107004292_107004443 | 4.14 |
Olfr2 |
olfactory receptor 2 |
1327 |
0.26 |
chr7_72738318_72738569 | 4.11 |
Gm7693 |
predicted gene 7693 |
24822 |
0.19 |
chr8_44377835_44377986 | 4.10 |
Gm37972 |
predicted gene, 37972 |
149365 |
0.04 |
chr18_8301550_8301706 | 4.09 |
Gm20147 |
predicted gene, 20147 |
73622 |
0.11 |
chr9_78537160_78537490 | 4.07 |
Gm47430 |
predicted gene, 47430 |
16779 |
0.13 |
chr16_44526696_44526873 | 4.06 |
Mir3081 |
microRNA 3081 |
31345 |
0.16 |
chr7_31127074_31128340 | 4.06 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr4_32923442_32923826 | 4.06 |
Ankrd6 |
ankyrin repeat domain 6 |
129 |
0.96 |
chr12_79390092_79390243 | 4.04 |
Rad51b |
RAD51 paralog B |
62814 |
0.12 |
chr5_148265155_148265692 | 4.03 |
Mtus2 |
microtubule associated tumor suppressor candidate 2 |
78 |
0.98 |
chr14_12393556_12393971 | 4.01 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr15_23452243_23452457 | 3.99 |
Gm6533 |
predicted gene 6533 |
37541 |
0.18 |
chr12_108037358_108037909 | 3.95 |
Bcl11b |
B cell leukemia/lymphoma 11B |
34031 |
0.2 |
chr9_124439906_124440949 | 3.94 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr4_49041678_49042070 | 3.94 |
Plppr1 |
phospholipid phosphatase related 1 |
17399 |
0.23 |
chr5_122094478_122094843 | 3.93 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
6291 |
0.15 |
chr9_41889978_41890642 | 3.93 |
Gm40513 |
predicted gene, 40513 |
294 |
0.89 |
chr1_84710201_84710701 | 3.92 |
Dner |
delta/notch-like EGF repeat containing |
14230 |
0.15 |
chr18_37218144_37218452 | 3.89 |
Gm10544 |
predicted gene 10544 |
39776 |
0.08 |
chr10_81429712_81431957 | 3.89 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr12_53698600_53698751 | 3.86 |
1700060O08Rik |
RIKEN cDNA 1700060O08 gene |
380717 |
0.01 |
chr19_40575539_40576017 | 3.86 |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
12591 |
0.11 |
chr10_59957812_59958054 | 3.83 |
Ddit4 |
DNA-damage-inducible transcript 4 |
6099 |
0.19 |
chr16_72889520_72889671 | 3.83 |
Robo1 |
roundabout guidance receptor 1 |
86754 |
0.11 |
chrX_166971783_166971961 | 3.83 |
Gm44376 |
predicted gene, 44376 |
14773 |
0.17 |
chr14_12338097_12338549 | 3.78 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr17_34301046_34301240 | 3.77 |
Gm20513 |
predicted gene 20513 |
4577 |
0.09 |
chr13_110280472_110281172 | 3.77 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr9_27454354_27454543 | 3.73 |
Spata19 |
spermatogenesis associated 19 |
56923 |
0.12 |
chr7_62231071_62231594 | 3.73 |
Gm9801 |
predicted gene 9801 |
21853 |
0.21 |
chr7_134725562_134725843 | 3.71 |
Dock1 |
dedicator of cytokinesis 1 |
51753 |
0.15 |
chr12_25871193_25871842 | 3.71 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr5_136293141_136293512 | 3.69 |
Cux1 |
cut-like homeobox 1 |
9195 |
0.15 |
chr13_57332049_57332200 | 3.69 |
Gm48176 |
predicted gene, 48176 |
55446 |
0.16 |
chr2_34904909_34905764 | 3.65 |
Phf19 |
PHD finger protein 19 |
429 |
0.72 |
chr11_67668112_67668294 | 3.64 |
Gas7 |
growth arrest specific 7 |
13969 |
0.19 |
chr2_30721610_30722285 | 3.63 |
Mir3089 |
microRNA 3089 |
737 |
0.55 |
chr4_72800139_72800290 | 3.62 |
Aldoart1 |
aldolase 1 A, retrogene 1 |
52418 |
0.16 |
chr3_108017789_108018699 | 3.62 |
Gstm1 |
glutathione S-transferase, mu 1 |
271 |
0.75 |
chr11_58948518_58949018 | 3.61 |
H2bu2 |
H2B.U histone 2 |
152 |
0.86 |
chr1_177150301_177150519 | 3.61 |
Gm38146 |
predicted gene, 38146 |
14957 |
0.16 |
chr9_56236129_56236280 | 3.60 |
Gm29322 |
predicted gene 29322 |
4547 |
0.15 |
chr3_34558947_34559118 | 3.60 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1296 |
0.39 |
chr1_170367644_170367795 | 3.59 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
40065 |
0.13 |
chr12_44839950_44840386 | 3.59 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr5_134101398_134101557 | 3.57 |
Castor2 |
cytosolic arginine sensor for mTORC1 subunit 2 |
1472 |
0.31 |
chr1_84695084_84695464 | 3.56 |
Mir5126 |
microRNA 5126 |
565 |
0.52 |
chr7_129937635_129938453 | 3.54 |
Gm4265 |
predicted gene 4265 |
24121 |
0.24 |
chr18_40459021_40459343 | 3.54 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
chr6_36691584_36691805 | 3.53 |
Gm25111 |
predicted gene, 25111 |
7703 |
0.26 |
chr4_48924626_48925013 | 3.52 |
Gm12436 |
predicted gene 12436 |
26226 |
0.17 |
chr14_93887009_93887408 | 3.51 |
Pcdh9 |
protocadherin 9 |
984 |
0.68 |
chr18_60770031_60770182 | 3.49 |
Rps14 |
ribosomal protein S14 |
4490 |
0.15 |
chr8_36457363_36458468 | 3.48 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr17_4040209_4040609 | 3.48 |
4930470H14Rik |
RIKEN cDNA 4930470H14 gene |
42586 |
0.19 |
chr13_38410275_38410887 | 3.47 |
Bmp6 |
bone morphogenetic protein 6 |
16136 |
0.17 |
chr4_65814253_65814420 | 3.46 |
Trim32 |
tripartite motif-containing 32 |
209087 |
0.03 |
chr7_87110681_87110885 | 3.44 |
Gm44925 |
predicted gene 44925 |
8084 |
0.27 |
chr14_64589182_64589588 | 3.44 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
310 |
0.8 |
chr2_154477070_154477221 | 3.44 |
Cbfa2t2 |
CBFA2/RUNX1 translocation partner 2 |
33391 |
0.12 |
chr13_4231095_4231533 | 3.43 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
2426 |
0.22 |
chr2_48538627_48539050 | 3.43 |
Gm13481 |
predicted gene 13481 |
81593 |
0.1 |
chrX_42361720_42361910 | 3.42 |
Gm14619 |
predicted gene 14619 |
14303 |
0.27 |
chr4_32325733_32325955 | 3.42 |
Bach2it1 |
BTB and CNC homology 2, intronic transcript 1 |
74083 |
0.1 |
chr12_15768596_15768748 | 3.41 |
Mir6387 |
microRNA 6387 |
32429 |
0.14 |
chr6_14142085_14142437 | 3.41 |
Gm23760 |
predicted gene, 23760 |
28945 |
0.21 |
chr10_13171046_13171455 | 3.41 |
Zc2hc1b |
zinc finger, C2HC-type containing 1B |
6773 |
0.19 |
chr1_41431202_41431374 | 3.41 |
Gm28634 |
predicted gene 28634 |
98255 |
0.09 |
chr2_173264522_173264902 | 3.40 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
11477 |
0.18 |
chr16_87040534_87040685 | 3.40 |
Gm38477 |
predicted gene, 38477 |
8651 |
0.28 |
chr2_94273064_94274137 | 3.39 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr16_90706305_90706649 | 3.37 |
Mis18a |
MIS18 kinetochore protein A |
20662 |
0.13 |
chr13_26119473_26119648 | 3.37 |
Gm11352 |
predicted gene 11352 |
75141 |
0.12 |
chr1_18181257_18181437 | 3.35 |
Crisp4 |
cysteine-rich secretory protein 4 |
35445 |
0.14 |
chr15_58214312_58215724 | 3.35 |
Fbxo32 |
F-box protein 32 |
86 |
0.89 |
chr3_85299790_85299992 | 3.34 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17628 |
0.24 |
chr10_46011889_46012235 | 3.33 |
Gpx4-ps2 |
glutathione peroxidase 4, pseudogene 2 |
136757 |
0.05 |
chr19_22703987_22704138 | 3.33 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
11240 |
0.26 |
chr1_14755119_14756069 | 3.32 |
Gm9947 |
predicted gene 9947 |
140 |
0.64 |
chr5_20056465_20056826 | 3.32 |
Gm23570 |
predicted gene, 23570 |
35970 |
0.2 |
chr1_56738751_56738938 | 3.32 |
Hsfy2 |
heat shock transcription factor, Y-linked 2 |
101409 |
0.08 |
chr2_178805310_178805611 | 3.31 |
Gm14314 |
predicted gene 14314 |
215673 |
0.02 |
chr13_93073637_93073972 | 3.31 |
Gm4814 |
predicted gene 4814 |
425 |
0.85 |
chr10_67978939_67980119 | 3.30 |
Rtkn2 |
rhotekin 2 |
41 |
0.98 |
chr2_94122628_94122854 | 3.30 |
Hsd17b12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
35152 |
0.14 |
chr6_50358160_50358718 | 3.28 |
Osbpl3 |
oxysterol binding protein-like 3 |
6482 |
0.27 |
chr16_14265466_14265813 | 3.27 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr9_13246797_13247848 | 3.27 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr16_48672889_48673104 | 3.27 |
Gm8670 |
predicted gene 8670 |
77452 |
0.09 |
chr14_79843110_79843311 | 3.26 |
Gm6999 |
predicted gene 6999 |
6498 |
0.18 |
chr1_179327030_179327181 | 3.25 |
Smyd3 |
SET and MYND domain containing 3 |
46998 |
0.18 |
chr13_43531802_43532067 | 3.25 |
Gm32939 |
predicted gene, 32939 |
1714 |
0.28 |
chr7_122499925_122500076 | 3.25 |
Gm14389 |
predicted gene 14389 |
15580 |
0.17 |
chr17_30518861_30519375 | 3.24 |
Btbd9 |
BTB (POZ) domain containing 9 |
5443 |
0.17 |
chr13_51919172_51919359 | 3.23 |
Gm26651 |
predicted gene, 26651 |
53949 |
0.13 |
chr9_95257001_95257349 | 3.23 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
135489 |
0.04 |
chr10_43625591_43625924 | 3.23 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
2010 |
0.24 |
chr6_36931501_36931832 | 3.23 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
5382 |
0.26 |
chr8_28602186_28602351 | 3.22 |
Gm26795 |
predicted gene, 26795 |
8736 |
0.28 |
chr2_170336226_170336795 | 3.22 |
Bcas1 |
breast carcinoma amplified sequence 1 |
13230 |
0.18 |
chr12_13706665_13706816 | 3.22 |
Gm35890 |
predicted gene, 35890 |
37887 |
0.13 |
chr6_40023721_40024003 | 3.21 |
Gm37995 |
predicted gene, 37995 |
3032 |
0.29 |
chr3_146327151_146327444 | 3.21 |
Gm43334 |
predicted gene 43334 |
2877 |
0.24 |
chr6_112809545_112809826 | 3.20 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr5_37716863_37717819 | 3.19 |
Stk32b |
serine/threonine kinase 32B |
170 |
0.96 |
chr15_32002923_32003126 | 3.16 |
Gm49285 |
predicted gene, 49285 |
46927 |
0.18 |
chr6_33947005_33947225 | 3.16 |
Gm13853 |
predicted gene 13853 |
45296 |
0.16 |
chr9_75609468_75609796 | 3.16 |
Tmod2 |
tropomodulin 2 |
1443 |
0.33 |
chr7_136342594_136342745 | 3.15 |
C230079O03Rik |
RIKEN cDNA C230079O03 gene |
6746 |
0.21 |
chr4_124881310_124881874 | 3.14 |
Epha10 |
Eph receptor A10 |
693 |
0.52 |
chr2_74128845_74129526 | 3.14 |
Gm28640 |
predicted gene 28640 |
996 |
0.55 |
chr17_13572187_13572614 | 3.13 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
3536 |
0.2 |
chr1_50647049_50647200 | 3.13 |
Gm20118 |
predicted gene, 20118 |
114094 |
0.07 |
chr4_45473113_45473714 | 3.13 |
Shb |
src homology 2 domain-containing transforming protein B |
9389 |
0.16 |
chr12_16649986_16650144 | 3.13 |
Lpin1 |
lipin 1 |
3099 |
0.2 |
chr9_49796724_49798126 | 3.13 |
Ncam1 |
neural cell adhesion molecule 1 |
1333 |
0.53 |
chr7_79543992_79544179 | 3.12 |
Gm35040 |
predicted gene, 35040 |
8042 |
0.09 |
chr11_41644936_41645522 | 3.12 |
Gm12142 |
predicted gene 12142 |
54107 |
0.15 |
chr13_63985565_63985750 | 3.11 |
Gm7695 |
predicted gene 7695 |
39136 |
0.14 |
chr4_131432917_131433068 | 3.11 |
Gm831 |
predicted gene 831 |
54205 |
0.16 |
chr12_60821059_60821415 | 3.11 |
Gm38172 |
predicted gene, 38172 |
45355 |
0.18 |
chr9_58815921_58816146 | 3.11 |
Hcn4 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 4 |
7379 |
0.24 |
chr1_25830497_25830737 | 3.10 |
Gm9884 |
predicted gene 9884 |
40 |
0.93 |
chr18_32017434_32017762 | 3.09 |
Gm16344 |
predicted gene 16344 |
4142 |
0.15 |
chr15_92051061_92051263 | 3.08 |
Cntn1 |
contactin 1 |
3 |
0.98 |
chr2_93227298_93227486 | 3.08 |
Tspan18 |
tetraspanin 18 |
394 |
0.88 |
chr18_57259582_57259777 | 3.08 |
Gm50200 |
predicted gene, 50200 |
55461 |
0.11 |
chr1_118825166_118825848 | 3.08 |
Gm28467 |
predicted gene 28467 |
15371 |
0.24 |
chr10_13412707_13412858 | 3.08 |
Phactr2 |
phosphatase and actin regulator 2 |
23812 |
0.22 |
chr6_58862605_58862983 | 3.08 |
Herc3 |
hect domain and RLD 3 |
35 |
0.98 |
chr15_86751686_86751958 | 3.07 |
4930543I03Rik |
RIKEN cDNA 4930543I03 gene |
13996 |
0.2 |
chr18_13397132_13397486 | 3.07 |
Gm50093 |
predicted gene, 50093 |
25220 |
0.24 |
chr3_69588417_69588708 | 3.07 |
B3galnt1 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 |
10398 |
0.17 |
chr14_34892319_34892570 | 3.07 |
Mir346 |
microRNA 346 |
2165 |
0.38 |
chr19_37991486_37991747 | 3.06 |
Myof |
myoferlin |
24490 |
0.17 |
chr11_42314956_42315148 | 3.06 |
Gabra6 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6 |
5997 |
0.32 |
chr14_26118223_26119106 | 3.06 |
Duxbl2 |
double homeobox B-like 2 |
191 |
0.91 |
chr2_137560427_137560578 | 3.05 |
Gm14064 |
predicted gene 14064 |
102933 |
0.08 |
chr4_118620310_118621356 | 3.05 |
Ebna1bp2 |
EBNA1 binding protein 2 |
15 |
0.52 |
chr16_43506266_43506527 | 3.05 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1761 |
0.44 |
chr14_118001575_118002132 | 3.05 |
Dct |
dopachrome tautomerase |
25682 |
0.18 |
chr4_24669747_24669918 | 3.04 |
Klhl32 |
kelch-like 32 |
5595 |
0.3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.4 | 2.7 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.3 | 4.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.3 | 3.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.2 | 3.7 | GO:0060166 | olfactory pit development(GO:0060166) |
1.2 | 8.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.2 | 7.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.1 | 3.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.0 | 3.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.0 | 2.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.0 | 8.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.0 | 3.0 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.0 | 3.0 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
1.0 | 3.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 3.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.0 | 4.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.9 | 2.8 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.9 | 2.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 2.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 1.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.9 | 2.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 2.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 2.7 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.9 | 2.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 2.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.8 | 1.7 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.8 | 3.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 3.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 3.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.8 | 2.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 2.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.8 | 2.3 | GO:0046959 | habituation(GO:0046959) |
0.8 | 2.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 2.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 1.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.7 | 3.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.7 | 6.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 3.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 1.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.6 | 7.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 2.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 1.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.6 | 1.9 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 5.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 3.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 2.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 1.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 1.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.6 | 2.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.6 | 1.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 1.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.6 | 3.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.6 | 2.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 5.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.6 | 3.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 2.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 1.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 1.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.5 | 1.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 1.6 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.5 | 3.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.5 | 1.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.5 | 1.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 2.6 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.5 | 2.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 1.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 1.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.5 | 1.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 1.0 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.5 | 1.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 2.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.5 | 1.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 1.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 1.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.5 | 1.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 1.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.5 | 3.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.5 | 0.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 1.4 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 2.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.5 | 3.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 1.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.5 | 1.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 1.9 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.5 | 3.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 1.4 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.5 | 0.5 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.5 | 1.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 1.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 5.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 1.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 0.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.4 | 2.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 1.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.4 | 1.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 1.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.4 | 2.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.4 | 1.2 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 1.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.4 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 2.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.6 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 1.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.4 | 4.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 3.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.4 | 1.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 2.3 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 1.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.4 | 1.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 0.7 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 1.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 2.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 1.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 2.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.4 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.4 | 0.4 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.4 | 0.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 1.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 0.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 2.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 3.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.3 | 2.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.3 | 0.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.3 | 0.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 1.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 5.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.3 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 1.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 1.5 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.3 | 0.9 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.3 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.3 | 1.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 2.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 0.6 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.3 | 1.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.3 | 1.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 4.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 0.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.3 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 0.3 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
0.3 | 0.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.3 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.8 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 1.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 0.3 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.3 | 1.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 0.5 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.3 | 0.5 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 1.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.3 | 0.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 0.3 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.3 | 2.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 2.7 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 2.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.5 | GO:0060433 | bronchus development(GO:0060433) |
0.2 | 0.7 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 1.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.2 | 1.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 0.7 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.2 | 1.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 1.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 3.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.5 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.2 | 2.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.2 | 1.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.2 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.2 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 0.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 2.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 3.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 4.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 1.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.2 | 0.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 2.1 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.4 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 0.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.4 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.8 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.2 | 2.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 1.2 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.4 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.6 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
0.2 | 1.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 1.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.6 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.4 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 1.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.4 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.2 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.2 | 0.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.5 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 1.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.2 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 2.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.2 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.6 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.3 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.2 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.6 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.5 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.2 | 0.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 0.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.9 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.6 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.6 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 1.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 1.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 1.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 5.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.1 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 14.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 1.0 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 1.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 6.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.3 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.5 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.4 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 1.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.3 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.4 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.6 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.4 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 8.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 1.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.1 | 0.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 2.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 1.0 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.3 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.1 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.5 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.5 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.3 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 1.3 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.1 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 1.1 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 0.1 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 1.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 1.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.5 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.2 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 1.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 1.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.1 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.7 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 1.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.9 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.5 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 1.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.8 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.1 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.1 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.6 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.2 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.1 | 0.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 1.8 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.6 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.1 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.0 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.0 | 0.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 5.4 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.2 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.1 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.1 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.0 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0060572 | morphogenesis of an epithelial bud(GO:0060572) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.0 | 0.1 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 0.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 6.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.9 | 7.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 2.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 2.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 1.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.8 | 2.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 2.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 2.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 6.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 1.9 | GO:0072534 | perineuronal net(GO:0072534) |
0.5 | 4.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 5.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 1.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 2.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 2.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.4 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 3.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 2.3 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 3.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 6.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 3.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.4 | 1.8 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.8 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 5.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 6.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.3 | 0.5 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 7.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 1.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 14.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 3.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.7 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 8.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.2 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 1.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 2.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 2.5 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 4.3 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 2.5 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.7 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 5.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 16.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 7.1 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 3.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 14.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 6.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 3.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.1 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 2.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 1.0 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.6 | GO:0030016 | myofibril(GO:0030016) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.0 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.5 | 6.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.2 | 3.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.2 | 3.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.0 | 3.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 3.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 3.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.9 | 3.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 2.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 4.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.8 | 4.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.8 | 1.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.8 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 3.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.8 | 3.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 2.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 2.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 0.7 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.7 | 2.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.6 | 2.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 1.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 5.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 3.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.5 | 3.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.5 | 2.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 2.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 1.5 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 1.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.5 | 2.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 1.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 3.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.4 | 2.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 2.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 2.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 3.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 2.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.4 | 5.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.4 | 2.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 3.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 2.9 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.4 | 1.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 1.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.3 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.9 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 5.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 0.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 4.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 4.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.3 | 1.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.3 | 0.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 1.5 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.3 | 1.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 3.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.2 | 0.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 1.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 1.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 4.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.6 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 2.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 3.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 1.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 1.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 2.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 1.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 5.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 4.2 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 0.7 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 2.2 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 4.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.5 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 4.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.5 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 3.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 3.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.4 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 3.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 1.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 1.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 3.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 6.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 1.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.9 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 2.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 3.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 10.3 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.1 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 1.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.1 | 0.9 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.0 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.4 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 2.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 1.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 1.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 3.1 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 1.0 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 7.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 8.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 4.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 1.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 5.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 5.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 5.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 1.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 4.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 4.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 4.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 1.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 13.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 1.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 4.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 7.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 0.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.3 | 9.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.2 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 4.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 4.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 11.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 3.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 3.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 3.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 4.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 1.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 5.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 3.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.2 | 1.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 4.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 7.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 6.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 2.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 2.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |